In The News Posted June 19, 2019 Share Posted June 19, 2019 SYRACUSE, N.Y., June 19, 2019 /PRNewswire/ -- Quadrant Biosciences Inc., a developer of epigenetic diagnostic technologies, has been awarded a $330,000 grant from the National Institutes of Health (NIH). This grant supplements a previously awarded $2 million Phase II grant related to... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.